Covid

Delhi’s Apollo Hospital likely to administer Russian Sputnik V vaccine from June 20

The Russian-made Sputnik V coronavirus vaccine will likely be administered at the Indraprastha Apollo Hospital in New Delhi starting next week, said the hospital.

UPDATED: June 13, 2021 23:52 IST

Russia’s Sputnik V coronavirus vaccine will likely be administered at the Indraprastha Apollo Hospital in New Delhi later this month. Hyderabad-based Dr Reddy’s Laboratories has partnered with the Russian Direct Investment Fund (RDIF) for the rollout of the two-dose vaccine in India.

The Apollo Group of Hospitals said it has received 1,000 doses of the Sputnik V vaccine. Around 170 of these doses were administered to employees of Dr Reddy’s Laboratories at the Apollo Hospital in New Delhi on Sunday.

Sources said the Indraprastha Apollo Hospital is only facilitating the vaccination of Dr Reddy’s employees for now.

In a statement, Apollo Group of Hospitals said it is waiting for more doses of the Russian-made vaccine to arrive. People will be able to receive the Sputnik V vaccine at Apollo likely by June 20, said the hospital.

The Sputnik V vaccine will also be available at the Madhukar Rainbow Children’s Hospital in New Delhi in the coming week, reported news agency PTI.

Sputnik V in India

Apart from Apollo hospitals, Sputnik V is also being administered at Continental hospitals in Hyderabad.

The price of each dose of the Sputnik V vaccine has been capped at Rs 1,145 by the central government. Private hospitals administering the vaccine have been directed to charge only the capped price, in addition to Rs 150 as a service charge per dose.

Dr Reddy’s Laboratories and Apollo Hospitals initiated the first phase of the Sputnik V roll-out on May 17 in Hyderabad. The vaccine was then made available in Vishakhapatnam on May 18 on a pilot basis.

On June 10, the RDIF announced that the efficacy of the Sputnik V vaccine as recorded during an inoculation drive-by Bahrain’s Ministry of Health was estimated to be at 94.3 per cent.

Dr Reddy’s Laboratories CEO (API and Services), Deepak Sapra, told India Today TV last month that the pharma company is working with Indian regulators to also bring the single-dose Sputnik Light vaccine to India.

Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
%d bloggers like this: